OLIGODISC Trademark

Trademark Overview


On Friday, August 29, 2025, a trademark application was filed for OLIGODISC with the United States Patent and Trademark Office. The USPTO has given the OLIGODISC trademark a serial number of 79438362. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 4, 2025. This trademark is owned by Contera Pharma A/S. The OLIGODISC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and developing algorithms and thermodynamic models.
oligodisc

General Information


Serial Number79438362
Word MarkOLIGODISC
Filing DateFriday, August 29, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, December 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs); designing and developing algorithms and thermodynamic models.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 4, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameContera Pharma A/S
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressDK

Trademark Events


Event DateEvent Description
Thursday, December 4, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 5, 2025APPLICATION FILING RECEIPT MAILED